Telangana Chief Minister Revanth Reddy discussed the state's investment progress. He aims for projects worth Rs 1 lakh crore this year, highlighting Hyderabad's appeal to global investors and its ...

Ajay Gnanamuthu recently married his long-time girlfriend Shimona in Chennai. Actor Vishal visited to congratulate them, sparking collaboration rumors. Ajay, known for 'Demonte Colony' and ...

Pharmaceutical major Dr Reddy's Laboratories is slated to release its October-December earnings report on January 23. Marking a shift from previous quarters of solid growth, the company's net ...

The ‘TelanganaRising’ delegation led by Chief Minister A. Revanth Reddy landed in Zurich, Switzerland on Monday (January 20, 2025) morning after their successful visit to Singapore.

Indian pharmaceutical major, Dr Reddy’s Laboratories, is scheduled to deliver its October-December quarterly earnings for the financial year 2024-25 (Q3FY25) on Thursday, January 23, 2025. According ...

Her first film, Azaad, is a historical drama directed by Abhishek Kapoor, featuring a cast that includes the likes of Ajay Devgn, Diana Penty, Mohit Malik, and Piyush Mishra. The film, that also ...

Check out the numbers here. Azaad box office collection day 1: Aaman Devgan and Ajay Devgn in a still from the film. Azaad earned around ₹1.50 crore net in India on its first day, as per early ...

If you’ve been curious about the relationship between newcomer Aaman Devgan and Ajay Devgn, then you’ve landed on the right page. Read on to learn how they are related. Shivangi Sarkar Editorial ...

Lok Sabha Elections 2024: Anupamaa' Star Rupali Ganguly Joins BJP, Says 'Big Fan' Of PM Modi Salman Khan House Firing Case: Accused Anuj Thapan Dies By Suicide In Mumbai Police Custody Lok Sabha ...

Actor Vishal has announced that he is teaming up with ace director Gautham Menon and Demonte Colony-maker Ajay Gnanamuthu for two of his upcoming films. The actor said this while revealing his ...

BofA has chosen Dr. Reddy's Laboratories Ltd. as its top pick in the Indian pharma space, as its sees earnings visibility in the near term. Two years of outperformance-boosted valuation and gross ...